logo
Digital Science to strengthen research integrity in publishing with new Dimensions Author Check API

Digital Science to strengthen research integrity in publishing with new Dimensions Author Check API

Yahoo16-07-2025
LONDON, July 16, 2025 (GLOBE NEWSWIRE) -- Scholarly publishers can now fully integrate research integrity checks into their editorial and submission workflows, thanks to Digital Science's new Dimensions Author Check API, which launches today.
Built on Dimensions – the world's largest interconnected global research database – Dimensions Author Check evaluates researchers' publication and collaboration histories within seconds, delivering reliable, concise, structured insights.
For the first time, the new Dimensions Author Check API enables publishers to embed this functionality directly into their own workflows, without the need to switch to an outside platform.
Dr Leslie McIntosh, Vice President of Research Integrity at Digital Science, said Dimensions Author Check API is designed to support consistent and confident editorial decision-making.
'By highlighting key indicators of research integrity – such as retractions, tortured phrases, or unusual co-authorship patterns – the Dimensions Author Check API helps to rapidly identify potential issues for concern. These include continuously improving indicators that will identify paper mills and increase trust in science,' Dr McIntosh said.
'Importantly, the Author Check API can do this at scale, giving publishers the ability to screen multiple researchers per request. This makes it ideal for high-volume manuscript processing and broader editorial oversight.'
Key benefits of the new Dimensions Author Check API include:
Seamless integration: A standards-based RESTful API designed for easy deployment within publishers' internal systems or third-party platforms.
Actionable insights: Clear summaries highlighting key aspects of researchers' publication and collaboration histories.
Operational efficiency: Reducing editorial workload while enhancing the quality and consistency of integrity assessments.
Support for transparency and trust: Surfacing critical integrity information at key decision points, strengthening publishers' ability to adhere to ethical standards.
For more information or to explore integration options, please contact the Digital Science Publisher Team.
Note to editors: The Dimensions Author Check dashboard was originally announced in December last year. This announcement is specific to the Dimensions Author Check API, which launches today.
About Dimensions
Part of Digital Science, Dimensions hosts the largest collection of interconnected global research data, re-imagining research discovery with access to grants, publications, clinical trials, patents and policy documents all in one place. Follow Dimensions on Bluesky, X and LinkedIn.
About Digital Science
Digital Science is an AI-focused technology company providing innovative solutions to complex challenges faced by researchers, universities, funders, industry and publishers. We work in partnership to advance global research for the benefit of society. Through our brands – Altmetric, Dimensions, Figshare, IFI CLAIMS Patent Services, metaphacts, OntoChem, Overleaf, ReadCube, Symplectic, and Writefull – we believe when we solve problems together, we drive progress for all. Visit digital-science.com and follow Digital Science on Bluesky, on X or on LinkedIn.
CONTACT: Media contact David Ellis, Press, PR & Social Manager, Digital Science: Mobile +61 447 783 023, d.ellis@digital-science.comSign in to access your portfolio
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Consortium 'ready' to buy ailing Morecambe
Consortium 'ready' to buy ailing Morecambe

Yahoo

time27 minutes ago

  • Yahoo

Consortium 'ready' to buy ailing Morecambe

London-based sports investment company Panjab Warriors have released a statement to say they are "ready, willing and able" to buy Morecambe. The Shrimps were suspended by the National League until 20 August on Monday over failing to comply with the league's rules. Panjab Warriors have been in talks with the club's owner Jason Whittingham for over a year and a deal had looked set to be concluded earlier this summer. They have now said in a joint-statement with minority shareholders, the Shrimps Trust and Lizzi Collinge MP that the National League is ready to sanction the deal and "immediately lift the suspension and embargo should it be agreed". BBC investigates takeover turmoil behind Morecambe suspension Morecambe suspended from the National League Morecambe owner 'not heard from' potential bidder As it stands, Morecambe's fixture away to Boston United on 9 August, their first home game against Brackley Town on 16 August, and the trip to Scunthorpe United on 19 August, will no longer take place as scheduled. Whittingham, who has been looking to sell the club since 2022, announced a new buyer, named as a consortium led by Jonny Cato, had been found earlier in July, but it remains unclear where that bid also stands. Whittingham said on Sunday he had "not heard from" Panjab Warriors in the past week and talks with Cato were ongoing. The Lancashire side, who were promoted to League One in 2021, were relegated from League Two last season - their second relegation in the past three seasons.

How AI Is Finally Tackling America's Unclaimed Duty Crisis
How AI Is Finally Tackling America's Unclaimed Duty Crisis

Forbes

timean hour ago

  • Forbes

How AI Is Finally Tackling America's Unclaimed Duty Crisis

In international trade, one of the best-kept secrets is also the most expensive: over $10 billion in refundable tariffs goes unclaimed each year. Despite being legally entitled to recover these funds, companies fail to file duty drawback claims on an estimated 78% to 85% of eligible transactions. Enter a new wave of AI-powered trade management companies that have collectively raised tens of millions in venture capital over the past eighteen months. The latest of these is Caspian, which just emerged from stealth with $5.4 million in seed funding led by Primary Venture Partners. The San Francisco-based company, founded by ex-Flexport engineers Justin Sherlock and Matt Ebeweber, focuses specifically on duty drawback—the process of reclaiming tariffs paid on imported goods that are later re-exported. Caspian founders: Justin Sherlock and Matt Ebeweber This follows a surge of venture-backed players in the broader supply chain space, suggesting investors see significant opportunity across the trade technology spectrum as tariffs dominate international headlines. London-based bagged $2.2 million in seed funding last year from Fuel Ventures and Plug and Play Ventures for its AI compliance platform. And Altana raised a splashy $200 million Series C to address global value chains. Market Forces Fueling Growth The numbers tell a compelling story about both opportunity and market growth. Estimates vary, but the global trade management software market is expected to exceed $2.2B by 2032, growing at a Compound Annual Growth Rate (CAGR) of roughly 8.4%. Despite this expanding market, the duty drawback opportunity remains largely untapped. In 2017, the total amount claimed was about $838 million, but by 2023, this figure had increased to an estimated $3.9 billion. This trajectory suggests businesses are becoming more aware of drawback opportunities, but it also underscores how much money has historically been left on the table. The venture-backed players entering this space face an interesting dynamic: They're not just competing for market share in an existing software category, but essentially creating demand for a service many businesses don't realize they need. "After working for over a decade in trade with brands and manufacturers struggling to navigate this overly complex process, we thought there had to be a better solution for businesses to manage tariff exposure,' said Justin Sherlock, founder and CEO of Caspian. 'Over 90% of eligible businesses are leaving cash on the table because claiming duty refunds is so painful. We built Caspian to leverage AI alongside our expert staff to make organizations' trade data usable, making claims more compliant and refunds easier to recover.' Trade Technology Market Positioning The Hidden Cost of Complexity Billions of dollars are left unclaimed every year. Many businesses pay duties on imports without realizing they could get that money back. The reasons are telling: duty drawback involves navigating a maze of regulations, matching import and export records across years of transactions, and filing paperwork with U.S. Customs and Border Protection — a process that can take months using traditional methods. This complexity has created a peculiar market dynamic. Most existing solutions focus on compliance and risk management, rather than financial recovery. The established competitive landscape includes several categories of players. Software-centric companies like OCR Inc.'s EASE Enterprise Suite offer web-based automation with ERP integration, while full-service providers like J.M. Rodgers Co. (JMR) claim high recovery rates of up to 99% with their CBP-approved proprietary software. Logistics giants like DHL Global Forwarding and Flexport offer drawback services as part of broader trade solutions, while specialized consultants like TecEx and Tradewin focus on specific segments or geographic markets. Alliance Drawback Services and Livingston International represent the traditional consulting model, offering expertise-heavy approaches that promise high recovery rates but require significant manual oversight. Meanwhile, e-commerce focused players like Swap Commerce target high-volume returns using SKU and inventory tracking. The New Guard: AI-First Approaches to Trade Tech The current funding environment reflects broader investor enthusiasm for AI applications in traditionally manual sectors. AI startups received fifty-three percent of all global venture capital dollars invested in the first half of 2025, with trade technology representing a small but growing slice. The competitive dynamics are revealing. New entrants are targeting different stages of the trade process: Caspian focuses on financial recovery, on compliance, and others like Revenir AI on workflow automation. Together, they may challenge incumbents like OCR and J.M. Rodgers by offering faster, more streamlined alternatives to legacy systems.. This division of labor suggests the market is large enough to support multiple approaches, but also highlights the complexity of trade operations that no single solution can fully address. The duty drawback space has long been dominated by traditional customs brokers and consulting firms who charge hefty fees—often 30 to 40 percent of recovered duties—for manual, labor-intensive processes. Established players like Tradewin and larger customs brokerage firms have built businesses around this complexity, but their methods haven't fundamentally changed in decades. On the technology side, Oracle can help businesses check the eligibility of imports for duty drawback and help automate key processes such as document gathering, regulatory compliance, and filing duty drawback requests through its Global Trade Management suite. Similarly, OCR's duty drawback software solution allows for easy access to the data needed to recover duty paid to CBP, while MIC-CUST revolutionizes duty refund management by facilitating refunds of up to ninety-nine percent on duties, taxes, and fees. However, even established players like Flexport are doubling down on AI integration. In February 2025, the logistics giant rolled out a suite of new AI-powered tools, signaling that incumbents aren't ceding ground to startups without a fight. This creates an interesting dynamic where venture-backed specialists must compete not just with traditional brokers like DHL Global Forwarding and Alliance Drawback Services, but with well-funded incumbents rapidly deploying their own AI solutions. What sets the newcomers apart is their AI-first approach and, in e.g. Caspian's case, its rare distinction as both a licensed customs broker and CBP-approved technology vendor—a regulatory combination that allows it to file claims directly with customs authorities, similar to established players like J.M. Rodgers Co. but with modern automation capabilities. The Trump Factor: Tariffs as Business Reality The stakes have never been higher. President Trump's renewed focus on tariffs has dramatically increased the amounts businesses pay in duties, making recovery programs more valuable than ever. New reciprocal tariffs that went into effect earlier this year — with new deals rolling in — add an additional 10 percent ad valorem duty on most imported goods, creating fresh opportunities for drawback claims. This environment has forced businesses to reconsider their trade strategies. 'Centralizing this data and executing these cost savings so quickly is a game-changer for our margins and inventory planning,' said Jim Franz, President, North America at UltiMaker, a Netherlands-based manufacturer of 3D printers that uses Caspian. The AI Promise and Its Limits There is a broader trend toward using artificial intelligence to automate traditionally manual financial processes, while companies like focus on preventing compliance issues through better data classification and documentation, companies like Caspian lean towards AI. Both approaches promise significant time savings—Caspian claims to submit duty drawback claims in days rather than months, while automates customs clearance procedures that traditionally require extensive manual review. This tension between automation and expertise reflects a broader challenge facing the entire venture-backed trade tech sector. Yet they must navigate the same fundamental challenge that has allowed established players like J.M. Rodgers Co. and TecEx to maintain high recovery rates: trade regulations that require nuanced interpretation. The competitive benchmarks are daunting. Traditional providers like J.M. Rodgers and Alliance Drawback Services claim recovery rates of up to 99% of duties, with the ability to file retroactive claims up to three to five years prior. For venture-backed startups to succeed, they must not only match these recovery rates but do so while offering superior user experience and faster processing times. Market Dynamics and Consolidation Pressure The influx of venture capital into trade technology suggests investors believe the market is ripe for disruption. Primary Venture Partners' Emily Man frames it as creating an entirely new software vertical: "tariff management." However, the market faces natural consolidation pressures. Large enterprises often prefer working with established customs brokers who handle their full trade compliance needs rather than point solutions. Meanwhile, smaller businesses that could benefit most from automated duty drawback often lack the trade volume to justify the cost of any solution. This creates a challenging middle market opportunity that challenger companies must navigate carefully. Success will likely depend on demonstrating clear ROI while building the regulatory credibility that only comes with time and successful claim filings. The Regulatory Wild Card Perhaps the biggest unknown is how U.S. Customs and Border Protection (CBP) will adapt to increased automation in duty drawback filing. CBP completed sixty-seven audits in May that identified one hundred thirty-nine million dollars in duties and fees owed to the U.S. government, suggesting heightened scrutiny of all trade-related filings. While CBP has approved select technology vendors, the agency's capacity to handle a surge in automated claims remains untested. If AI-powered platforms dramatically increase filing volumes, it could create processing bottlenecks or trigger additional regulatory requirements. 'Long-term, we see ourselves as a strategic partner in modernizing U.S. trade infrastructure,' Sherlock says. 'We're helping businesses take advantage of export incentives to grow GDP and improve profitability for US-based inventory and manufacturing.' Looking Forward: Promise and Peril The emergence of AI-powered duty drawback solutions reflects a broader transformation in how businesses approach international trade costs. As tariffs become a more permanent feature of the economic landscape, tools that help companies optimize their trade expenses will likely see continued demand. Yet the industry faces fundamental questions about scalability, regulatory adaptation, and whether technology can truly solve problems rooted in policy complexity. Success will depend not just on technical capability, but on building trust with both customers and regulators in a field where mistakes can be costly. The billions of dollars in annual unclaimed duties represents a massive opportunity—but it also reflects the entrenched complexity that has kept money on the table for decades. Whether AI can finally unlock this value remains one of the most intriguing tests of automation's promise in financial services. For businesses struggling with rising tariff costs, the answer can't come soon enough. But in a field where regulatory compliance and financial recovery intersect, the path forward may prove more challenging than the technology alone suggests.

Maziar Mike Doustdar appointed as president and chief executive officer of Novo Nordisk
Maziar Mike Doustdar appointed as president and chief executive officer of Novo Nordisk

Yahoo

time3 hours ago

  • Yahoo

Maziar Mike Doustdar appointed as president and chief executive officer of Novo Nordisk

Bagsværd, Denmark, 29 July 2025 – Novo Nordisk today announced that Maziar Mike Doustdar has been appointed as president and chief executive officer, effective 7 August 2025. Mike Doustdar succeeds Lars Fruergaard Jørgensen, who will step down as president and chief executive officer on the same date. The company also announced other executive-level changes, effective 7 August. Mike Doustdar, currently Novo Nordisk's executive vice president of International Operations, has a strong track record of creating value and driving growth. Under his leadership over the past decade, Novo Nordisk's International Operations have more than doubled sales to approximately DKK 112 billion in 2024. The business includes all of Novo Nordisk's affiliates outside of the US and employs nearly 20,000 people. Novo Nordisk Chair, Helge Lund, said: 'Mike is an exceptional leader and has the unanimous support of the Board. We are confident that he is the best person to lead Novo Nordisk through its next growth phase. Mike has consistently demonstrated the ability to drive growth through strong commercial execution and building high-performing teams. This is an important moment for Novo Nordisk. The market is developing rapidly, and the company needs to address recent market challenges with speed and ambition. I believe Novo Nordisk will build on its strengths as a global leader in obesity and diabetes, and Mike has a clear vision of how to unlock the full potential of the opportunities ahead.' Mike Doustdar has been appointed as the result of a comprehensive process that included external and internal candidates. The Novo Nordisk Foundation fully endorses Novo Nordisk Board's decision to appoint Maziar Mike Doustdar as president and chief executive officer. Mike Doustdar said: 'It's an enormous privilege to lead this company at a time of tremendous opportunity and change. I come to this role with a sense of urgency, a laser focus on high performance, and a fierce determination for Novo Nordisk to aim higher than it's ever done, and to deliver to many more patients the innovation they need. From my decades in leadership roles across Novo Nordisk, I know the extraordinary talent and commitment of our people and the excellence of our science. This has enabled us to achieve great things in the past and will ensure we continue to do so in the future.' Novo Nordisk Chair, Helge Lund, added: 'Under Lars's leadership, Novo Nordisk has undergone a profound period of growth and now reaches millions more patients with life-changing medicines. On behalf of Novo Nordisk's Board of Directors and our employees, I want to thank Lars for 34 years of unstinting commitment to the company and wish him all the best in his future endeavours.' Other organisational changes effective 7 August: Research & Early Development and Development EVP areas will be merged into a combined R&D Nordisk has decided to merge the company's Research & Early Development with its Development area into a new, consolidated R&D unit, under the leadership of Martin Holst Lange, MD, PhD. Martin Holst Lange, currently executive vice president, Development, will be appointed chief scientific officer (CSO), effective 7 August. Martin Holst Lange will focus on seamlessly combining the two functions, quickly advancing the innovation of new therapies and ensuring the success of the early and late-stage pipelines, with a significant focus on the diabetes and obesity areas. In addition, Martin Holst Lange will work closely with Mike Doustdar to drive pipeline development and innovation from both within and outside of the company. Marcus Schindler, executive vice president, Research & Early Development and CSO, has decided to retire from the company. Novo Nordisk Chair, Helge Lund, said: 'We thank Marcus for his deep commitment to Novo Nordisk and its pursuit of scientific excellence. We wish him all the best for the future.' Marcus Schindler joined Novo Nordisk in January 2018 as senior vice president of External Innovation and Strategy and has been CSO since 2021. Marcus Schindler has played an integral role in leading the discovery of early scientific innovation. He will remain at Novo Nordisk for a short period to ensure a successful transition. Emil Kongshøj Larsen, currently senior vice president of the Europe and Canada region (EUCAN), will join Executive Management and succeed Mike Doustdar, assuming the responsibility of executive vice president, International Operations. Emil Larsen currently leads a region spanning 40 countries, accounting for about 20% of Novo Nordisk's global sales. He has previously led other significant business areas throughout Europe, Africa and the Middle East, as well as Commercial Affairs and Strategy in International Operations. With these changes, Executive Management will have the following members, effective 7 August: Maziar Mike Doustdar, president and CEO* Thilde Hummel Bøgebjerg, EVP, Quality, IT & Environmental Affairs Emil Kongshøj Larsen, EVP, International Operations Ludovic Helfgott, EVP, Product & Portfolio Strategy Karsten Munk Knudsen, EVP, chief financial officer* Martin Holst Lange, EVP, chief scientific officer, Research & Development David Moore, EVP, US Operations Tania Sabroe, EVP, People, Organisation and Corporate Affairs Henrik Wulff, EVP, CMC & Product Supply * Registered as an executive with the Danish Business Authority. About Maziar Mike DoustdarMike Doustdar became senior vice president of International Operations in 2013, a business that includes 80 affiliates - all of Novo Nordisk's commercial affiliates outside of the US. Novo Nordisk's International Operations had sales of approximately DKK 112 billion in 2024 and serve approximately 35 million patients. Prior to this role, Mike led Novo Nordisk's Southeast Asia and Oceania commercial area out of Malaysia, following on from his leadership of the Middle East business. Prior to this, he was general manager based in Turkey and held leadership roles in finance and IT. Mike Doustdar became executive vice president in 2015. He is a member of the Board of Directors of Orion Corporation. Conference CallNovo Nordisk will host a conference call for investors at 14.30 CEST on 29 July 2025, corresponding to 8.30 am EST. For more information on how to listen, please visit the investor section of There will be a conference call for media at 16.00 CEST, which corresponds to 10.00 am EST. Novo Nordisk is a leading global healthcare company founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines and working to prevent and ultimately cure disease. Novo Nordisk employs about 77,400 people in 80 countries and markets its products in around 170 countries. Novo Nordisk's B shares are listed on Nasdaq Copenhagen (Novo-B). Its ADRs are listed on the New York Stock Exchange (NVO). For more information, visit Facebook, Instagram, X, LinkedIn and YouTube. Contacts for further information Media: Ambre James-Brown +45 3079 9289abmo@ Liz Skrbkova (US)+1 609 917 0632lzsk@ Investors: Jacob Martin Wiborg Rode+45 3075 5956jrde@ Sina Meyer +45 3079 6656azey@ Max Ung+45 3077 6414 mxun@ Frederik Taylor Pitter +1 609 613 0568fptr@ Publication of inside information pursuant to Market Abuse Regulation, Article 17 Company announcement No 19 / 2025 Attachment CA250729-CEO-succession

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store